Schaapherder Alexander, Wijermars Leonie G M, de Vries Dorottya K, de Vries Aiko P J, Bemelman Frederike J, van de Wetering Jacqueline, van Zuilen Arjan D, Christiaans Maarten H L, Hilbrands Luuk H, Baas Marije C, Nurmohamed Azam S, Berger Stefan P, Alwayn Ian P, Bastiaannet Esther, Lindeman Jan H N
Department of Transplant Surgery, Leiden University Medical Center, Leiden, the Netherlands.
Department of Medicine, Division of Nephrology, Leiden University Medical Center, Leiden, the Netherlands.
EClinicalMedicine. 2018 Oct 9;4-5:25-31. doi: 10.1016/j.eclinm.2018.09.007. eCollection 2018 Oct-Nov.
Despite growing waiting lists for renal transplants, hesitations persist with regard to the use of deceased after cardiac death (DCD) renal grafts. We evaluated the outcomes of DCD donations in The Netherlands, the country with the highest proportion of DCD procedures (42.9%) to test whether these hesitations are justified.
This study included all procedures with grafts donated after brain death (DBD) (n = 3611) and cardiac death (n = 2711) performed between 2000 and 2017. Transplant outcomes were compared by Kaplan Meier and Cox regression analysis, and factors associated with short (within 90 days of transplantation) and long-term graft loss evaluated in multi-variable analyses.
Despite higher incidences of early graft loss (+ 50%) and delayed graft function (+ 250%) in DCD grafts, 10-year graft and recipient survival were similar for the two graft types (Combined 10-year graft survival: 73.9% (95% CI: 72.5-75.2), combined recipient survival: 64.5% (95 CI: 63.0-66.0%)). Long-term outcome equivalence was explained by a reduced impact of delayed graft function on DCD graft survival (RR: 0.69 (95% CI: 0.55-0.87), p < 0.001). Mid and long-term graft function (eGFR), and the impact of incident delayed graft function on eGFR were similar for DBD and DCD grafts.
Mid and long term outcomes for DCD grafts are equivalent to DBD kidneys. Poorer short term outcomes are offset by a lesser impact of delayed graft function on DCD graft survival. This nation-wide evaluation does not justify the reluctance to use of DCD renal grafts. A strong focus on short-term outcome neglects the superior recovery potential of DCD grafts.
尽管肾移植等待名单不断增加,但对于使用心脏死亡后捐献者(DCD)的肾移植仍存在犹豫。我们评估了荷兰DCD捐献的结果,该国DCD手术比例最高(42.9%),以检验这些犹豫是否合理。
本研究纳入了2000年至2017年间所有接受脑死亡后捐献者(DBD)(n = 3611)和心脏死亡后捐献者(n = 2711)肾脏移植的手术。通过Kaplan Meier和Cox回归分析比较移植结果,并在多变量分析中评估与短期(移植后90天内)和长期移植失败相关的因素。
尽管DCD移植的早期移植失败发生率较高(增加50%)和移植功能延迟发生率较高(增加250%),但两种移植类型的10年移植和受者生存率相似(联合10年移植生存率:73.9%(95%CI:72.5 - 75.2),联合受者生存率:6开4.5%(95%CI:63.0 - 66.0%))。移植功能延迟对DCD移植生存的影响降低解释了长期结果的等效性(风险比:0.69(95%CI:0.55 - 0.87),p < 0.001)。DBD和DCD移植的中期和长期移植功能(估算肾小球滤过率)以及移植功能延迟对估算肾小球滤过率的影响相似。
DCD移植的中期和长期结果与DBD肾脏相当。较差的短期结果被移植功能延迟对DCD移植生存的较小影响所抵消。这种全国性评估并不能证明不愿使用DCD肾移植的合理性。过于关注短期结果忽视了DCD移植的优越恢复潜力。